Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study
Crossref DOI link: https://doi.org/10.1007/s12325-016-0472-9
Published Online: 2017-01-09
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Albayaty, Muna
Linden, Margareta
Olsson, HĂ„kan
Johnsson, Markus
StrandgÄrden, Kerstin
Tiberg, Fredrik
Funding for this research was provided by:
Camurus AB
License valid from 2017-01-09